News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
drsandeepnayak.com
Feb 7, 2025, 13:19

Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma

Yasser Mohamed Ali Ged, GU Medical Oncologist at Johns Hopkins Kimmel Cancer Center, shared on X:

“Our paper on IO combinations in metastatic translocation RCC is now online. Great collaborative work and addition to treatment outcomes in this rare entity.”

Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma

Authors: Ged, Yasser; Touma, Amina; Meza Contreras, Luis; Elias, Roy; Van Galen, Joseph; Cupo, Olivia; Baraban, Ezra; Singla, Nirmish; Lee, Chung-Han; Pal, Sumanta; Zibelman, Matthew; Kotecha, Ritesh R.

Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma

 

 

cancer OncoDaily Oncology renal cell carcinoma Yasser Mohamed Ali Ged
Special Coverage
Blog
Feb 7, 2025, 13:19
Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
Career
Feb 7, 2025, 13:18
Pfizer Announced Jeffrey Legos As Their New Chief Oncology Officer
Blog
Feb 7, 2025, 13:16
Kamila Naxerova: Quantifying cell divisions along evolutionary lineages in cancer
Blog
Feb 7, 2025, 13:15
Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma
Blog
Feb 7, 2025, 13:13
Paolo Tarantino: Grateful to receive a Research Award from METAvivor to advance MBC research
Science
Feb 7, 2025, 13:10
Advances in Hepatocellular Carcinoma: A Comprehensive Update on Epidemiology, Diagnosis, and Treatment
Blog
Feb 7, 2025, 13:09
Donna Feild: Highlighting the success stories, the breakthroughs that have improved the quality of life for patients worldwide
Science
Feb 7, 2025, 12:58
Myeloma Paper of the Day, February 7th, suggested by Robert Orlowski
Drugs
Feb 7, 2025, 12:36
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Blog
Feb 7, 2025, 12:34
Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes
Drugs
Feb 7, 2025, 12:32
Benjamin Weinberg: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
Blog
Feb 7, 2025, 12:26
Gustavo Viani: The Case for Two-Fraction SBRT in Prostate Cancer Treatment